Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
1.15
Oct 26 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
41.32M
Enterprise Value
166.39M
Income
5.86M
Sales
183.53M
Book/sh
-2.38
Cash/sh
0.31
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
223
IPO
Apr 28, 2021
P/E
9.55
Forward P/E
4.84
PEG
-
P/S
0.23
P/B
-
P/C
3.70
P/FCF
2.08
EV/EBITDA
6.42
EV/Sales
0.91
Quick Ratio
0.81
Current Ratio
1.43
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
0.12
EPS next Y
0.24
EPS next Q
-0.01
EPS this Y
-96.28%
EPS next Y
763.64%
EPS next 5Y
-12.25%
EPS past 3/5Y
- 11.37%
Sales past 3/5Y
5.23% 10.52%
EPS Y/Y TTM
-82.99%
Sales Y/Y TTM
-7.81%
EPS Q/Q
-328.61%
Sales Q/Q
-9.48%
Insider Own
18.76%
Insider Trans
2.51%
Inst Own
61.97%
Inst Trans
-9.26%
ROA
5.67%
ROE
-
ROIC
9.92%
Gross Margin
66.93%
Oper. Margin
12.03%
Profit Margin
3.19%
SMA20
2.47%
SMA50
-12.38%
SMA200
-37.99%
Trades
Shs Outstand
27.66M
Shs Float
23.30M
52W High
3.01 -61.79%
52W Low
1.00 15.00%
Volatility
11.40% 9.01%
ATR (14)
0.11
RSI (14)
46.76
Beta
1.73
Rel Volume
0.00
Avg Volume
214.08K
Volume
0
Perf Week
6.48%
Perf Month
-5.74%
Perf Quarter
-48.66%
Perf Half Y
-49.34%
Perf YTD
-55.77%
Perf Year
-60.21%
Perf 3Y
-77.76%
Perf 5Y
-88.19%
Perf 10Y
-
Prev Close
1.15
Price
1.15
Change %
0.00%
Date Action Analyst Rating Change Price Target Change
Aug-07-25Downgrade B. Riley Securities Buy → Neutral $4
Dec-16-24Initiated Craig Hallum Buy
Feb-20-24Initiated B. Riley Securities Buy $9
Feb-01-24Initiated Jefferies Buy
Jun-24-22Initiated Cowen Outperform $11
Jun-23-22Initiated ROTH Capital Buy $9
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Beer Marc DExecutive ChairmanAug 10 '26Buy1.53115,950177,404223,744Aug 12 04:25 PM
Beer Marc DExecutive ChairmanAug 11 '26Buy1.5516,00024,800239,744Aug 12 04:25 PM
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.
Executive ChairmanMr. Marc D. Beer
Interim CEOMr. Robert C. Peterson
Chief Information OfficerMr. John J. Olsen
General CounselMr. Dan Monico
Chief Digital OfficerMr. Richard Kevin Key